Rimm DL - Search Results

1

Macrophage colony-stimulating factor-1 receptor expression is associated with poor outcome in breast cancer by large cohort tissue microarray analysis.

Kluger HM, Dolled-Filhart M, Rodov S, Kacinski BM, Camp RL, Rimm DL. Kluger HM, et al. Among authors: rimm dl. Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):173-7. doi: 10.1158/1078-0432.ccr-0699-3. Clin Cancer Res. 2004. PMID: 14734466

2

The cell adhesion molecule, E-cadherin, distinguishes mesothelial cells from carcinoma cells in fluids.

Schofield K, D'Aquila T, Rimm DL. Schofield K, et al. Among authors: rimm dl. Cancer. 1997 Oct 25;81(5):293-8. Cancer. 1997. PMID: 9349517

3

Localization and quantitation of expression of the cell motility-related protein thymosin beta15 in human breast tissue.

Gold JS, Bao L, Ghoussoub RA, Zetter BR, Rimm DL. Gold JS, et al. Among authors: rimm dl. Mod Pathol. 1997 Nov;10(11):1106-12. Mod Pathol. 1997. PMID: 9388061

4

The expression of p120ctn protein in breast cancer is independent of alpha- and beta-catenin and E-cadherin.

Dillon DA, D'Aquila T, Reynolds AB, Fearon ER, Rimm DL. Dillon DA, et al. Among authors: rimm dl. Am J Pathol. 1998 Jan;152(1):75-82. Am J Pathol. 1998. PMID: 9422525 Free PMC article.

5

Expression of c-met is a strong independent prognostic factor in breast carcinoma.

Ghoussoub RA, Dillon DA, D'Aquila T, Rimm EB, Fearon ER, Rimm DL. Ghoussoub RA, et al. Among authors: rimm eb, rimm dl. Cancer. 1998 Apr 15;82(8):1513-20. doi: 10.1002/(sici)1097-0142(19980415)82:8<1513::aid-cncr13>3.0.co;2-7. Cancer. 1998. PMID: 9554529

6

Loss of p120ctn in human colorectal cancer predicts metastasis and poor survival.

Gold JS, Reynolds AB, Rimm DL. Gold JS, et al. Among authors: rimm dl. Cancer Lett. 1998 Oct 23;132(1-2):193-201. doi: 10.1016/s0304-3835(98)00190-6. Cancer Lett. 1998. PMID: 10397474 Free article.

7

Met expression is associated with poor outcome in patients with axillary lymph node negative breast carcinoma.

Camp RL, Rimm EB, Rimm DL. Camp RL, et al. Among authors: rimm eb, rimm dl. Cancer. 1999 Dec 1;86(11):2259-65. doi: 10.1002/(sici)1097-0142(19991201)86:11<2259::aid-cncr13>3.0.co;2-2. Cancer. 1999. PMID: 10590366

8

A high number of tumor free axillary lymph nodes from patients with lymph node negative breast carcinoma is associated with poor outcome.

Camp RL, Rimm EB, Rimm DL. Camp RL, et al. Among authors: rimm eb, rimm dl. Cancer. 2000 Jan 1;88(1):108-13. Cancer. 2000. PMID: 10618612

9

Validation of tissue microarray technology in breast carcinoma.

Camp RL, Charette LA, Rimm DL. Camp RL, et al. Among authors: rimm dl. Lab Invest. 2000 Dec;80(12):1943-9. doi: 10.1038/labinvest.3780204. Lab Invest. 2000. PMID: 11140706 Free article.

10

Beta-catenin dysregulation in thyroid neoplasms: down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosis.

Garcia-Rostan G, Camp RL, Herrero A, Carcangiu ML, Rimm DL, Tallini G. Garcia-Rostan G, et al. Among authors: rimm dl. Am J Pathol. 2001 Mar;158(3):987-96. doi: 10.1016/s0002-9440(10)64045-x. Am J Pathol. 2001. PMID: 11238046 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

513 results

Search Page

Filters